FDA approves once-monthly Abilify for schizophrenia

(Reuters) - Regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news